🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Are you sick of all the noise and just want to know the latest in urology ? Subscribe to our new telegram channel for European Urology European Urology Open Science European Urology Oncology Eur Urol Focus .. easy as 🥧 link here >>> t.me/europeanurology

Bernie Bochner, MD Ashish M. Kamat, MD, MBBS Shilpa Gupta Bladder Cancer Advocacy Network Matt Galsky Sia Daneshmand, M.D. Matt Galsky Bladder preservation after clinical CR to NAC: Not ready for prime time. The stakes are high and we need to get this right. “Retrospective studies and anecdotes tell us what can be achieved but not necessarily what should be achieved or how it should be achieved”

Truly # 1️⃣ inclusive multi D global community tackling bladder cancer one step (one breakthrough) at a time Proud IBCG member

Join this Cleveland Clinic Urology crew for case by case discussion of challenging renal masses and management w/ review Amer. Urol. Assn. guidelines .. see everyone soon 🔜 #AUA25 #kidneycancer

This was a great debate .. 🥊 but we are still friends after 🇫🇷🇺🇸 Morgan Roupret #AUA25

First evidence of #bladdercancer hotspots near areas of high plastics processing .. in both water and air . Elegantly presented by Laura Elizabeth Davis as part of Bukavina Lab ongoing work >> ongoing biological mechanism of action work by Sahab Ram Cleveland Clinic Urology #microplastics

NIH Director Dr. Jay Bhattacharya has announced that the NIH Public Access Policy, originally slated to go into effect on 12/31/25 will now be effective 7/1/25. Read more in his statement: bit.ly/4jTQI4O

To restore the gut microbiome after antibiotics, the right diet (rich in carbohydrates, low in fat) was a better approach than fecal microbial transplants (in the experimental model) nature.com/articles/s4158… nature.com/articles/d4158…

ATTN UROLOGISTS: we’re working on a phase III trial re intravesical chemotherapy at the time of URS. We’d greatly appreciate your input via our TWO MIN survey (link below). DrBagrodia Aaron Potretzke Wesley Yip Felipe Pessoa.Rodrigo surveymonkey.com/r/ZDVSZHK

#AUA25 recap | Bladder Cancer Patients’ Microbiomes Can Influence How Chemotherapy Is Metabolized consultqd.clevelandclinic.org/bladder-cancer… via @clevelandclinic Laura Bukavina Betty Wang

Please use this barcode to register for the course if interested. Spaces are limited ! ASTS

With soaked shoes and smiling faces, we walk Bladder Cancer Advocacy Network to fuel research 🔬 and hope 🙏 Together, we can do it.. and your Cleveland Clinic GU team is here ❤️ #BladderCancer #BCANWalk Cleveland Clinic Urology

Excited for our growing collaboration with Cleveland Clinic Urology and Valar Labs>> empowering our #BladderCancer patients with precision based evidence for their cancer care

Join us for Bladder Cancer Advocacy Network webinar.. everyone is welcome as we discuss bladder cancer tx evolution and what’s exciting in #bladdercancer care for our patients ❤️ Matt Milowsky

POTOMAC trial- Durvalumab + BCG shows positive results for DFS in high-risk NMIBC vs BCG alone. sasanlimab (CREST) also had an EFS advantage here: HR 0.68. Consistent results in early disease is compelling. IO tox is relevant in risk/benefit ratio. astrazeneca.com/media-centre/p…